Pages that link to "Item:Q553031"
From MaRDI portal
The following pages link to Optimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimality (Q553031):
Displaying 7 items.
- Multi-treatment optimal response-adaptive designs for phase III clinical trials (Q744587) (← links)
- Optimal responses-adaptive designs based on efficiency, ethic, and cost (Q1782096) (← links)
- Response Adaptive Designs with Misclassified Responses (Q2839069) (← links)
- Compound optimal allocation for individual and collective ethics in binary clinical trials (Q3067018) (← links)
- Response adaptive designs with asymptotic optimality (Q4960928) (← links)
- What doesn’t work with Phase IV studies? A real experience from an Ethics Committee (Q5148497) (← links)
- Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach (Q5185882) (← links)
